nephrocalcinosis
nephrocalcinosis
Explore linked clinical trials. Standard reference: MONDO:00015678 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The GranStone Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hypercalcemia disease, injury, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-18 | NCT07828002 | |
| Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypocalcemia, Familial, Hypocalcemia, Male Urogenital Diseases, Musculoskeletal Abnormalities, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, endocrine system disorder, hypoparathyroidism, kidney disorder, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nephrocalcinosis, nephrolithiasis, nervous system disorder, neuromuscular disease, parathyroid gland disorder, urinary system disorder, urolithiasis | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05680818 | |
| Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypercalcemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hereditary disease, hypercalcemia disease, hypercalcemia, infantile, kidney disorder, metabolic disease, nephrocalcinosis, urinary system disorder | Recruiting | Phase 2 | 2026-06-22 | NCT03301038 | |
| Effective Dosing of Burosumab in XLH | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypophosphatemia, Familial, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, X-linked hypophosphatemic rickets, bone disorder, calcinosis, calcium metabolic disease, hereditary disease, hypophosphatemia, hypophosphatemic rickets, inborn errors of metabolism, inborn metal metabolism disorder, kidney disorder, metabolic disease, musculoskeletal system disorder, nephrocalcinosis, nutritional deficiency disease, nutritional disorder, phosphorus metabolism disease, renal tubular transport disease, rickets, urinary system disorder, vitamin D deficiency, vitamin deficiency disorder | Recruiting | Not stated | 2026-05-11 | NCT07183579 | |
| ADH1 and ADH2 Disease Monitoring Study (DMS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypocalcemia, Familial, Hypocalcemia, Male Urogenital Diseases, Musculoskeletal Abnormalities, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, autosomal dominant hypocalcemia, calcinosis, calcium metabolic disease, endocrine system disorder, hypoparathyroidism, kidney disorder, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nephrocalcinosis, nephrolithiasis, nervous system disorder, neuromuscular disease, parathyroid gland disorder, urinary system disorder, urolithiasis | Active, not recruiting | Not stated | 2026-04-30 | NCT05227287 | |
| Effect of Comprehensive Spa Care on Kidney and Urological Conditions: A Clinical Study in Adult Patients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Prostatism, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, calcinosis, calcium metabolic disease, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, urinary system disorder, urinary tract infection, urolithiasis | Recruiting | Not applicable | 2026-04-24 | NCT07435844 | |
| Is CYP24A1 Heterozygosity a Risk Factor for Nephrolithiasis? | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, calcinosis, calcium metabolic disease, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Not stated | 2025-12-02 | NCT07201701 | |
| Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis | Calculi, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Kidney Calculi, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, Urological Manifestations, calcinosis, calcium metabolic disease, cystinuria, endocrine system disorder, hereditary disease, hyperparathyroidism, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, parathyroid gland disorder, renal aminoaciduria, renal tubular transport disease, urinary system disorder, urolithiasis | Active, not recruiting | Not applicable | 2025-01-23 | NCT00169806 |